Topics: ACTA Members
We showcase ACTA Member news, stories and achievements
Events
-
-
Melanoma and Skin Cancer Trials Concept Development Workshop
-
Australasian Gastro-Intestinal Trials Group 22nd Annual Scientific Meeting
-
ACTA CEO update – October 2022
-
Clinical Trials (CT) Socials
-
2022 ACTA ASM including the Australian Registry ASM
-
ACTA’s 2021 Annual General Meeting and Advisory Council Meeting
-
ACTA CEO update – August 2022
News
-
Australian Clinical Trials Alliance celebrating and honouring clinical trials on International Clinical Trials Day
-
AMaRC: FRAIL-M
-
ANZFPS: ComeBACK
-
Breast Cancer Trials: An EXPERT trial to avoid unnecessary treatment
-
Accolades for Australian clinical trials at annual ACTA awards
-
NTA: STOP-MSU
-
St Vincent’s Sydney: BELINDA Study
-
ANZGOG’S OUTBACK Trial Among the Most Important Cervical Cancer Research Advances in the Past Year
-
ACTA congratulates ALLG on 50 years of clinical trials impact
-
ANZSA: SARC032
-
ANZGOG—improving life for women through cancer research
-
Successful 2021 ACTA ASM
-
ACTA welcomes $1.89b investment in Australian health and medical research including support for a National One Stop Shop
-
ANZCA: ROCKet trial
-
CTANZ: SUNRRISE & COVIDSurg
-
LIFEMend: a lifestyle approach to mental health
-
ACTA to offer free consumer ASM registrations
-
ANZCA: BRACE trial
-
TIA: Supporting the development of a COVID-19 Vaccine
-
Nominations now closed : 2024 ACTA Trial of the Year Awards
-
ANZUP: ENZAMET
-
Monash SPHPM—renewed funding for ASPREE and recruitment for STaREE
-
Inaugural Emerging Leader Investigator Awards
-
Australian Clinical Trials shine at annual ACTA Awards
-
PREDICT: BELLPIC
-
Jean Hailes for Women’s Health: NECST
-
Member profile: ICU Hood